Method and apparatus for determining relationships between medications and symptoms

• US 10,319,475 B1
• Filed: 06/15/2015
• Issued: 06/11/2019
• Est. Priority Date: 06/13/2014
• Status: Active Grant

• Current Assignee: Enigami Systems, Inc.
• Original Assignee: Enigami Systems, Inc.
• Inventors: Croan, Clifton D., Graf, William F.
• Primary Examiner(s): Pauls, John A
• Application Number:
  US14/739,723
• Time in Patent Office: 1,457 Days
• CPC Class Codes: G06Q 10/10 Office automation; Time management
• CPC Class Codes: G06Q 50/26 Government or public services business processes related to the transportation industry G06Q50/40
• CPC Class Codes: G16H 10/20 for electronic clinical trials or questionnaires
• CPC Class Codes: G16H 20/10 relating to drugs or medications, e.g. for ensuring correct administration to patients
• CPC Class Codes: G16H 50/20 for computer-aided diagnosis, e.g. based on medical expert systems

Abstract

In accordance with one embodiment, a method can be implemented that includes enlisting via a computer network a plurality of participants to report one or more effects of their respective usage of a substance; confirming that a prospective participant is located in a state where use of the substance is legal; receiving from each of the one or more participants via the computer network one or more self-assessment reports of any physical, emotional, or mental responses or any combination thereof to the substance; and processing the one or more self-assessment reports with a computer processor to determine if the substance has an effect on a particular symptom or condition.

Claims

1. A method comprising:

enlisting via a computer network a plurality of participants to report one or more experienced effects from their respective cannabinoid usage;

confirming that a prospective participant is located in a jurisdiction where use of cannabinoids is legal;

receiving from each of the one or more participants via the computer network one or more self-assessment reports of one or more physical, emotional, or mental reported effects or one or more combination thereof from the use of at least one administered cannabinoid product wherein the at least one administered cannabinoid product is associated with a particular cannabinoid profile;

processing the one or more self-assessment reports with a computer processor to determine a cannabinoid or combination of cannabinoids having an effect on a particular symptom or medical condition; and

recommending an administration of a particular product to a consumer to treat the particular symptom or medical condition.

2. The method of claim 1 wherein the processing the one or more self-assessment reports comprises:

statistically evaluating the one or more self-assessment reports with the computer processor to determine the cannabinoid or the combination of cannabinoids having the determined effect on the particular symptom or the particular medical condition.

3. The method of claim 1 wherein not all of the plurality of participants participate from the same country.

4. The method of claim 1 and wherein at least a portion of the participants participate anonymously.

5. The method of claim 1 and further comprising:

reporting an efficacy rating for a particular cannabinoid product in producing a designated-effect, wherein the designated effect can be physical, mental, or emotional or any combination thereof.

6. The method of claim 1 and further comprising:

certifying a particular cannabinoid or cannabinoid product as effective in treating a particular health condition or symptom.

7. The method of claim 1 and further comprising:

certifying a particular cannabinoid or cannabinoid product as effective in producing a particular physical, emotional, or mental certified effect or any combination thereof.

8. The method of claim 1 and further comprising:

providing a registration system for a cannabinoid manufacturer to register a cannabis product by product name and cannabinoid profile.

9. The method of claim 1 wherein a participant can enter information about a cannabis product by product name and cannabinoid profile.

10. The method of claim 1 and further comprising:

statistically analyzing the self-assessment reports with the computer processor to determine a combination of cannabinoids having an entourage effect.

11. The method of claim 1 and further comprising:

statistically analyzing the self-assessment reports with the computer processor to determine a combination of one or more cannabinoids having a synergistic effect with an over the counter medication, a prescription medication, or a combination thereof.

12. The method of claim 1 and further comprising:

certifying to an insurance company that a particular cannabinoid or cannabinoid product is effective in treating a particular health condition or symptom based on a statistical analysis of the self-assessment reports.

13. The method of claim 1 and further comprising:

certifying to a caregiver that a particular cannabinoid or cannabinoid product is effective in treating a particular health condition or symptom based on a statistical analysis of the self-assessment reports.

14. The method of claim 1 and further comprising:

certifying to a healthcare organization that a particular cannabinoid or cannabinoid product is effective in treating a particular health condition or symptom based on a statistical analysis of the self-assessment reports.

15. The method of claim 1 and further comprising:

certifying to a governmental entity that a particular cannabinoid or cannabinoid product is effective in treating a particular health condition or symptom based on a statistical analysis of the self-assessment reports.

16. The method of claim 1 and further comprising:

certifying to a commercial vendor that a particular cannabinoid or cannabinoid product is effective in treating a particular health condition or symptom based on a statistical analysis of the self-assessment reports.

17. The method of claim 1 wherein the recommending comprises:

recommending to the consumer a cannabinoid, combination of cannabinoids, or cannabinoid product.

18. The method of claim 1 wherein the recommending comprises:

recommending to the consumer one or more combinations of a cannabinoid, cannabinoid product, over the counter medication, or prescription medication.

19. The method of claim 17 and further comprising:

determining a physical, emotional, or mental desired effect or any combination thereof desired by a consumer prior to the recommending.

20. The method of claim 1 and further comprising:

inquiring with a participant about a cannabis product that the participant is not currently taking but has previously taken.

21. The method of claim 1 wherein confirming that the prospective participant is located in a jurisdiction where use of cannabinoids is legal comprises checking the internet protocol address of the prospective participant.

22. The method of claim 2 wherein the particular medical condition comprises a plurality of symptoms.

23. The method of claim 2 and further comprising:

reporting based on the statistical evaluation of the self-assessment reports an efficacy rating for a particular cannabinoid product in producing a designated effect, wherein the designated effect can be physical, mental, or emotional or any combination thereof.

24. The method of claim 22 and further comprising:

certifying a particular cannabinoid or cannabinoid product as effective in treating the particular medical condition or the particular symptom based on the statistical evaluation of the self-assessment reports.